Cardiovascular Thrombus: From Pathology and Clinical Presentations to Imaging, Pharmacotherapy and Interventions

ISBN-13: 9780128126158 / Angielski / Twarda / 2018 / 670 str.

On Topaz

Spis treści

Section 1. Pathology 1. Hemostasis and thrombosis 2. Vascular wall pathology- effect on thrombosis 3. Mechanisms of thrombosis and their relationship to atherosclerosis: Endothelial cell function and injury [trauma, infection] 4. Platelet aggregation in the pathogenesis of vascular ischemia conditions 5. Physical properties and morphologic features of thrombus 6. Pathology of arterial thrombosis 7. Thrombus types 8. The calcified thrombus: histopathology 9. Pathology of venous thrombosis 10. Hypercoagulopathy: acquired syndromes and thrombosis 11. Hypercoagulopathy: hereditary syndromes and thrombosis 12. Intra cardiac thrombosis: ventricles, atria, appendage and valves 13. Prosthetic surgical valves and TAVR thrombosis 14. Closure devices and thrombosis

Section 2. Clinical presentations 15. Thrombotic ischemic syndromes of the coronary circulation 16. Thrombotic ischemic syndromes of the brain 17. Thrombotic syndromes of the peripheral arterial circulation 18. Thrombosis of the splanchnic and mesenteric 19. Unique thrombus-containing lesions 20. Thrombosis of the venous system: DVT; portal vein; renal vein; Superior vena cava; Jugular; Budd-Chiari; cavernous sinus; cerebral 21. The angry thrombus phenomenon and the simultaneous thrombus in different vascular beds 22. Pulmonary embolism-acute 23. Pulmonary embolism: chronic 24. Platelets, thrombus and thrombosis in pregnancy 25. Atrial fibrillation and thromboembolism

Section 3. Diagnosis 26. Cardiovascular Thrombus classifications 27. Laboratory studies of thrombus and thrombosis 28. Imaging modalities

Section 4. Treatment Guidelines 29. The role of treatment guidelines-comparing the US and European approach to cardiovascular thrombus

Section 5. Pharmacotherapy 30. From Coumadin to the new anticoagulation agents 31. Antiplatelet agents: asa; heparins; LMH 32. Direct thrombin inhibitors 33. The 2b/3a receptor antagonists 34. Thienopyridines 35. Thrombolytic agents

Section 6. Interventions 36. Percutaneous approach: 37. Protection filters 38. Mechanical thrombectomy: Angiojet and X-Sizer 39. Stents: dedicated thrombus containing stent platforms 40. Extraction and vaporization devices: thrombocat and laser 41. LAA closure 42. Surgical approach

Section 6. Future trends 43. Pharmacotherapy and technology